BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Agustini B, Mohebbi M, Woods RL, McNeil JJ, Nelson MR, Shah RC, Murray AM, Ernst ME, Reid CM, Tonkin A, Lockery JE, Berk M; ASPREE Investigator Group. The association of antihypertensive use and depressive symptoms in a large older population with hypertension living in Australia and the United States: a cross-sectional study. J Hum Hypertens 2020;34:787-94. [PMID: 32001828 DOI: 10.1038/s41371-020-0303-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Chua AL, Mehla S, Orlova YY. Drug Safety in Episodic Migraine Management in Adults. Part 2: Preventive Treatments. Curr Pain Headache Rep 2022. [PMID: 35587859 DOI: 10.1007/s11916-022-01051-9] [Reference Citation Analysis]
2 van Sloten TT, Souverein PC, Stehouwer CD, Driessen JH. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and risk of depression among older people with hypertension. J Psychopharmacol 2022;:2698811221082470. [PMID: 35388727 DOI: 10.1177/02698811221082470] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Li Y, Fan Y, Sun Y, Alolga RN, Xiao P, Ma G. Antihypertensive Drug Use and the Risk of Depression: A Systematic Review and Network Meta-analysis. Front Pharmacol 2021;12:777987. [PMID: 34819866 DOI: 10.3389/fphar.2021.777987] [Reference Citation Analysis]
4 Cojocariu SA, Maștaleru A, Sascău RA, Stătescu C, Mitu F, Leon-Constantin MM. Neuropsychiatric Consequences of Lipophilic Beta-Blockers. Medicina (Kaunas) 2021;57:155. [PMID: 33572109 DOI: 10.3390/medicina57020155] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Zhang L, Bao Y, Tao S, Zhao Y, Liu M. The association between cardiovascular drugs and depression/anxiety in patients with cardiovascular disease: A meta-analysis. Pharmacol Res 2021;175:106024. [PMID: 34890773 DOI: 10.1016/j.phrs.2021.106024] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Empana JP, Boutouyrie P, Lemogne C, Jouven X, van Sloten TT. Microvascular Contribution to Late-Onset Depression: Mechanisms, Current Evidence, Association With Other Brain Diseases, and Therapeutic Perspectives. Biol Psychiatry 2021;90:214-25. [PMID: 34325805 DOI: 10.1016/j.biopsych.2021.04.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
7 Agustini B, Lotfaliany M, Woods RL, McNeil JJ, Nelson MR, Shah RC, Murray AM, Ernst ME, Reid CM, Tonkin A, Lockery JE, Williams LJ, Berk M, Mohebbi M; ASPREE Investigator Group. Patterns of Association between Depressive Symptoms and Chronic Medical Morbidities in Older Adults. J Am Geriatr Soc 2020;68:1834-41. [PMID: 32402115 DOI: 10.1111/jgs.16468] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
8 La Torre D, Verbeke K, Dalile B. Dietary fibre and the gut–brain axis: microbiota-dependent and independent mechanisms of action. Gut Microb 2021;2. [DOI: 10.1017/gmb.2021.3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
9 Boyce TG, Ballone NT, Certa KM, Becker MA. The Use of β-Adrenergic Receptor Antagonists in Psychiatry: A Review. J Acad Consult Liaison Psychiatry 2021;62:404-12. [PMID: 34210401 DOI: 10.1016/j.jaclp.2020.12.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
10 Colbourne L, Harrison PJ. Brain-penetrant calcium channel blockers are associated with a reduced incidence of neuropsychiatric disorders. Mol Psychiatry 2022. [PMID: 35618884 DOI: 10.1038/s41380-022-01615-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Jin S, Kostka K, Posada JD, Kim Y, Seo SI, Lee DY, Shah NH, Roh S, Lim YH, Chae SG, Jin U, Son SJ, Reich C, Rijnbeek PR, Park RW, You SC. Prediction of Major Depressive Disorder Following Beta-Blocker Therapy in Patients with Cardiovascular Diseases. J Pers Med 2020;10:E288. [PMID: 33352870 DOI: 10.3390/jpm10040288] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Calvi A, Fischetti I, Verzicco I, Belvederi Murri M, Zanetidou S, Volpi R, Coghi P, Tedeschi S, Amore M, Cabassi A. Antidepressant Drugs Effects on Blood Pressure. Front Cardiovasc Med 2021;8:704281. [PMID: 34414219 DOI: 10.3389/fcvm.2021.704281] [Reference Citation Analysis]
13 Cui F, Zhang N, Yi J, Liang Y, Liu Q. Influence of Hostility on 24-Hour Diastolic Blood Pressure Load in Hypertension Patients with Depressive Disorders. Med Sci Monit 2021;27:e929710. [PMID: 33640897 DOI: 10.12659/MSM.929710] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Kessing LV, Rytgaard HC, Ekstrøm CT, Torp-Pedersen C, Berk M, Gerds TA. Antihypertensive Drugs and Risk of Depression: A Nationwide Population-Based Study. Hypertension 2020;76:1263-79. [PMID: 32829669 DOI: 10.1161/HYPERTENSIONAHA.120.15605] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 5.5] [Reference Citation Analysis]
15 Segarra AB, Prieto I, Martínez-Cañamero M, Ramírez-Sánchez M. Is there a link between depression, neurochemical asymmetry and cardiovascular function? AIMS Neurosci 2020;7:360-72. [PMID: 33263075 DOI: 10.3934/Neuroscience.2020022] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Colbourne L, Luciano S, Harrison PJ. Onset and recurrence of psychiatric disorders associated with anti-hypertensive drug classes. Transl Psychiatry 2021;11:319. [PMID: 34039956 DOI: 10.1038/s41398-021-01444-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]